Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Senior

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Toxicologic Pathology|April 5, 2005
Recognizing drug-induced liver injury: current problems, possible solutionsWilliam M Lee, John R Senior
The New England Journal of Medicine|February 17, 2006
Drug-related hepatotoxicityVictor J Navarro, John R Senior
Hepatology (Baltimore, Md.)|August 3, 2011
The Australia antigen and role of the late Philadelphia General Hospital in reducing post-transfusion hepatitis and sequelaeJohn R Senior, W Thomas London, Alton I Sutnick
The American Journal of Medicine|April 12, 2003
Troglitazone-induced liver failure: a case studyDavid J Graham, Lanh Green, John R Senior, et al.
Hepatology (Baltimore, Md.)|October 15, 2008
Using controlled clinical trials to learn more about acute drug-induced liver injuryPaul B Watkins, Paul J Seligman, John S Pears, et al.
Drug Safety|October 30, 2014
The clinical liver safety assessment best practices workshop: rationale, goals, accomplishments and the futurePaul B Watkins, Michael Merz, Mark I Avigan, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Toxicologic Pathology|April 5, 2005
Recognizing drug-induced liver injury: current problems, possible solutionsWilliam M Lee, John R Senior
The New England Journal of Medicine|February 17, 2006
Drug-related hepatotoxicityVictor J Navarro, John R Senior
Hepatology (Baltimore, Md.)|August 3, 2011
The Australia antigen and role of the late Philadelphia General Hospital in reducing post-transfusion hepatitis and sequelaeJohn R Senior, W Thomas London, Alton I Sutnick
The American Journal of Medicine|April 12, 2003
Troglitazone-induced liver failure: a case studyDavid J Graham, Lanh Green, John R Senior, et al.
Hepatology (Baltimore, Md.)|October 15, 2008
Using controlled clinical trials to learn more about acute drug-induced liver injuryPaul B Watkins, Paul J Seligman, John S Pears, et al.
Drug Safety|October 30, 2014
The clinical liver safety assessment best practices workshop: rationale, goals, accomplishments and the futurePaul B Watkins, Michael Merz, Mark I Avigan, et al.
Pageof 2